Global Equities Roundup: Market Talk

The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day.

0526 GMT - i-Tail Corp.'s growth outlook appears more stable, ttb wealth securities' Nuttapop Prasitsuksant says in a research report. Its earnings should grow by 21% in 2027, 16% in 2028 and 5% in 2029 after sharp volatility over 2023-2025 and a 2% decline in 2026, the analyst estimates. This view is partly backed by the Thai pet food manufacturer being a leading global pet food OEM that continues to gain share in this growing market. Also, its gross margins should improve in 2027-2028 thanks to drivers including rising plant utilization. The brokerage raises the stock's rating to buy from hold and the target price to 19.00 baht from 17.00 baht. Shares are 1.2% lower at 16.80 baht. (ronnie.harui@wsj.com)

0501 GMT - PolyNovo keeps its bulls at Morgans despite the medical-device maker's 2H revenue slowdown. Maintaining a buy rating on the stock, the Australian broker's analysts tell clients in a note that, while sales disappointed, cash generation is strong. They think this indicates the wound-treatment specialist is in a good position to deliver material Ebitda growth in each of its next two fiscal years. Morgans analysts say they remain confident that revenue growth can return above-20% levels in fiscal 2027, pointing out that 15.5% U.S. sales growth in fiscal 2026 was said by management to reflect some seasonality and shifts in insurance reimbursements. Morgans cuts its target price by 5.1% to 1.48 Australian dollars. Shares are down 3.4% at A$0.85. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

July 30, 2026 01:26 ET (05:26 GMT)